The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II trial of pembrolizumab (pembro) plus 1 mg/kg ipilimumab (ipi) immediately following progression on anti-PD-1 Ab in melanoma (mel).
 
Daniel Olson
No Relationships to Disclose
 
Jason J. Luke
Honoraria - Intellisphere, LLC
Consulting or Advisory Role - 7 Hills Pharma; Actym Therapeutics; Amgen; Array BioPharma; AstraZeneca/MedImmune; Benevir; Bristol-Myers Squibb; Castle Biosciences; Checkmate Pharmaceuticals; EMD Serono; Gilead Sciences; Janssen; Merck; Newlink Genetics; Novartis; Reflexion Medical; Syndax; Tempest Therapeutics
Research Funding - Abbvie; Boston Biomedical; Bristol-Myers Squibb; Celldex; Checkmate Pharmaceuticals; Corvus Pharmaceuticals; Delcath Systems; Five Prime Therapeutics; Genentech/Roche; Immunocore; Incyte; Macrogenics; MedImmune; Merck; Novartis; Palleon Pharmaceuticals; Pharmacyclics; Tesaro
Travel, Accommodations, Expenses - Amgen; Array BioPharma; AstraZeneca/MedImmune; Benevir; Bristol-Myers Squibb; Castle Biosciences; Checkmate Pharmaceuticals; EMD Serono; Gilead Sciences; Janssen; Merck; Novartis; Reflexion Medical
 
Sigrun Hallmeyer
Employment - Advocate Health Care; Oncology Specialists
Leadership - Advocate Lutheran General Hospital; Oncology Specialists
Honoraria - Bristol-Myers Squibb; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Cardinal Health; Karyo Biologics
Speakers' Bureau - Bristol-Myers Squibb; Pfizer
Research Funding - Russell Research (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Cardinal Health
 
Madhuri Bajaj
No Relationships to Disclose
 
Timothy Carll
No Relationships to Disclose
 
Thomas Krausz
No Relationships to Disclose
 
Yuanyuan Zha
No Relationships to Disclose
 
Theodore Karrison
No Relationships to Disclose
 
Bruce Brockstein
Consulting or Advisory Role - Blueprint Medicines
Research Funding - AstraZeneca (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate. Author and Editorial dutues
Expert Testimony - Pfizer
 
Vernon K. Sondak
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck/Schering Plough; Novartis; Provectus
 
Zeynep Eroglu
Consulting or Advisory Role - Compugen
Travel, Accommodations, Expenses - Genentech/Roche; Tesaro
 
Thomas Gajewski
Consulting or Advisory Role - Abbvie; Aduro Biotech; Amgen; Bayer; FORMA Therapeutics; Jounce Therapeutics; Merck; Roche/Genentech
Research Funding - Bristol-Myers Squibb (Inst); Incyte (Inst); Merck (Inst); Ono Pharmaceutical (Inst); Roche/Genentech (Inst); Seagen (Inst)
Patents, Royalties, Other Intellectual Property - Licensing to Evelo (Inst)
 
Nikhil I. Khushalani
Stock and Other Ownership Interests - Bellicum Pharmaceuticals; Mazor Robotics
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; EMD Serono; Regeneron
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); HUYA Bioscience International (Inst); Merck (Inst); Novartis (Inst)